Linda C Laux

  • 1461 Citations
20072020
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

My clinical and research focus is epilepsy syndromes, genetics of epilepsy syndromes, and Dravet syndrome.

Certifications and Licenses

Clinical Neurophysiology
Child Neurology

Training Experience

1993Residency, University of Arizona Health Science Center
1997Fellowship, Saint Joseph's Hospital, Phoenix
2001Fellowship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital)

Education/Academic qualification

MD, Saint Louis University

… → 1990

Research interests

  • EEG
  • Epigenetics
  • Epilepsy
  • Pediatric Neurology

Fingerprint Dive into the research topics where Linda C Laux is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Myoclonic Epilepsy Medicine & Life Sciences
Seizures Medicine & Life Sciences
Cannabidiol Medicine & Life Sciences
Epilepsy Medicine & Life Sciences
Ketogenic Diet Medicine & Life Sciences
Anticonvulsants Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Brain Diseases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2013 2014

Dravet Syndrome Database

Laux, L. C.

Dravet Syndrome Foundation

9/1/139/30/14

Project: Research project

Research Output 2007 2020

  • 1461 Citations
  • 27 Article
  • 1 Comment/debate
  • 1 Letter

A single-center, retrospective analysis of genotype-phenotype correlations in children with Dravet syndrome

Gertler, T. S., Calhoun, J. & Laux, L., Feb 2020, In : Seizure. 75, p. 1-6 6 p.

Research output: Contribution to journalArticle

Myoclonic Epilepsy
Genetic Association Studies
Anticonvulsants
Comorbidity
Seizures
2 Citations (Scopus)

Fenfluramine for Treatment-Resistant Seizures in Patients with Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial

Nabbout, R., Mistry, A., Zuberi, S., Villeneuve, N., Gil-Nagel, A., Sanchez-Carpintero, R., Stephani, U., Laux, L., Wirrell, E., Knupp, K., Chiron, C., Farfel, G., Galer, B. S., Morrison, G., Lock, M., Agarwal, A. & Auvin, S., Jan 1 2019, (Accepted/In press) In : JAMA Neurology.

Research output: Contribution to journalArticle

Open Access
Myoclonic Epilepsy
Fenfluramine
Seizures
Randomized Controlled Trials
Placebos
3 Citations (Scopus)

Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial

FAiRE DS Study Group, Dec 21 2019, In : The Lancet. 394, 10216, p. 2243-2254 12 p.

Research output: Contribution to journalArticle

Myoclonic Epilepsy
Fenfluramine
Seizures
Placebos
Therapeutics
17 Citations (Scopus)

Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial

Devinsky, O., Nabbout, R., Miller, I., Laux, L. C., Zolnowska, M., Wright, S. & Roberts, C., Feb 1 2019, In : Epilepsia. 60, 2, p. 294-302 9 p.

Research output: Contribution to journalArticle

Cannabidiol
Myoclonic Epilepsy
Seizures
Therapeutics
Caregivers
10 Citations (Scopus)

Long-term safety and efficacy of cannabidiol in children and adults with treatmentresistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results

Laux, L. C., Bebin, E. M., Checketts, D., Chez, M., Flamini, R., Marsh, E. D., Miller, I., Nichol, K., Park, Y., Segal, E., Seltzer, L., Szaflarski, J. P., Thiele, E. A. & Weinstock, A., Aug 1 2019, In : Epilepsy Research. 154, p. 13-20 8 p.

Research output: Contribution to journalArticle

Open Access
Cannabidiol
Myoclonic Epilepsy
Seizures
Safety
Anticonvulsants